Smartphones aren’t cheap, but for many of us, they’ve become essential. We use them for work, communication, information, entertainment, and even paying bills. If you need a smartphone and a wireless ...

Modern Linux distributions are powerful operating systems that can fully replace Windows or macOS for many users. But there are still some Windows-only applications that may not be available for Linux ...

Do you need to repay your PPP loan? Matt Webber is an experienced personal finance writer, researcher, and editor. He has published widely on personal finance, marketing, and the impact of technology ...

The PGA TOUR has announced a meaningful enhancement to the Player Equity Program, expanding the scope of who will receive equity in PGA TOUR Enterprises moving forward. The top 50 players in the 2026 ...

With the combination of asciminib plus a TKI, 91% of CML patients had attained a major molecular response by month 36. Combining asciminib, a first-in-class BCL::ABL1 inhibitor, with a tyrosine kinase ...

Lead CML researcher discusses the evolution of a groundbreaking treatment and its effect on patient survival. When imatinib (Gleevec; Novartis), the first-ever tyrosine kinase inhibitor, made its ...

Embark on a fulfilling pharmacy career with our Pharmacy Technician Training Program. Our 16-week program allows you to gain the skills required for safe patient care. The self-paced format ensures ...

Stephanie Watson is a freelance writer whose work has appeared in numerous consumer health publications, including WebMD, Greatist, Healthgrades, HealthCentral, SurvivorNet, Harvard Health ...

Asciminib, a first-in-class BCR-ABL1 TKI, showed high molecular response rates and was well tolerated in the first prospective trial of its kind evaluating the drug as a dose-escalated second-line ...

IMproveMF update: Phase 1/1B trial of imetelstat (IME)+ruxolitinib (RUX) in patients (pts) with intermediate (INT)-1, INT-2, or high-risk (HR) myelofibrosis (MF). This is an ASCO Meeting Abstract from ...

Risk of hypertension in patients newly diagnosed with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and treated with covalent Bruton tyrosine kinase inhibitors (cBTKi): A ...

If this is true, it opens up a Pandora’s box of problems alongside the benefits. What is the future of Microsoft’s Xbox consoles? A lot of PlayStation fans are eager to discourse about how the console ...